Carbonic Anhydrase Inhibition with Benzenesulfonamides and Tetrafluorobenzenesulfonamides Obtained via Click Chemistry
- PMID: 25147616
- PMCID: PMC4137363
- DOI: 10.1021/ml500196t
Carbonic Anhydrase Inhibition with Benzenesulfonamides and Tetrafluorobenzenesulfonamides Obtained via Click Chemistry
Abstract
A series of novel benzene- and 2,3,5,6-tetrafluorobenzenesulfonamide was synthesized by using a click chemistry approach starting from azido-substituted sulfonamides and alkynes, incorporating aryl, alkyl, cycloalkyl, and amino-/hydroxy-/halogenoalkyl moieties. The new compounds were medium potency inhibitors of the cytosolic carbonic anhydrase (CA, EC 4.2.1.1) isoforms I and II and low nanomolar/subnanomolar inhibitors of the tumor-associated hCA IX and XII isoforms. The X-ray crystal structure of two such sulfonamides in adduct with hCA II allowed us to understand the factors governing inhibitory power.
Keywords: Carbonic anhydrase; benzenesulfonamide; click chemistry; human isoform I; human isoform II; human isoform IX; human isoform XII.
Figures
Similar articles
-
Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors.J Enzyme Inhib Med Chem. 2016;31(2):205-11. doi: 10.3109/14756366.2015.1014477. Epub 2015 Sep 4. J Enzyme Inhib Med Chem. 2016. PMID: 25792500
-
5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.Bioorg Med Chem. 2013 Sep 1;21(17):5130-8. doi: 10.1016/j.bmc.2013.06.041. Epub 2013 Jun 27. Bioorg Med Chem. 2013. PMID: 23859774
-
Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.Bioorg Med Chem. 2011 May 15;19(10):3105-19. doi: 10.1016/j.bmc.2011.04.005. Epub 2011 Apr 6. Bioorg Med Chem. 2011. PMID: 21515057
-
7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII.J Enzyme Inhib Med Chem. 2016 Dec;31(6):1226-33. doi: 10.3109/14756366.2015.1115401. Epub 2015 Dec 18. J Enzyme Inhib Med Chem. 2016. PMID: 26681367
-
Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.Bioorg Med Chem. 2014 Mar 1;22(5):1586-95. doi: 10.1016/j.bmc.2014.01.031. Epub 2014 Jan 31. Bioorg Med Chem. 2014. PMID: 24513184
Cited by
-
Click chemistry approaches for developing carbonic anhydrase inhibitors and their applications.J Enzyme Inhib Med Chem. 2023 Jan 6;38(1):2166503. doi: 10.1080/14756366.2023.2166503. J Enzyme Inhib Med Chem. 2023. PMID: 36637011 Free PMC article. Review.
-
Fluorinated triazoles as privileged potential candidates in drug development-focusing on their biological and pharmaceutical properties.Front Chem. 2022 Aug 9;10:926723. doi: 10.3389/fchem.2022.926723. eCollection 2022. Front Chem. 2022. PMID: 36017163 Free PMC article. Review.
-
Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile.J Enzyme Inhib Med Chem. 2022 Dec;37(1):857-865. doi: 10.1080/14756366.2022.2051023. J Enzyme Inhib Med Chem. 2022. PMID: 35296197 Free PMC article.
-
Synthesis, Bioactivity Assessment, and Molecular Docking of Non-sulfonamide Benzimidazole-Derived N-Acylhydrazone Scaffolds as Carbonic Anhydrase-II Inhibitors.ACS Omega. 2021 Dec 20;7(1):705-715. doi: 10.1021/acsomega.1c05362. eCollection 2022 Jan 11. ACS Omega. 2021. PMID: 35036737 Free PMC article.
-
Thiazole Ring-A Biologically Active Scaffold.Molecules. 2021 May 25;26(11):3166. doi: 10.3390/molecules26113166. Molecules. 2021. PMID: 34070661 Free PMC article. Review.
References
-
- Mocharla V. P.; Colasson B.; Lee L. V.; Röper S.; Sharpless K. B.; Wong C. H.; Kolb H. C. In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Angew. Chem., Int. Ed. 2004, 44, 116–120. - PubMed
-
- Wilkinson B. L.; Innocenti A.; Vullo D.; Supuran C. T.; Poulsen S. A. Inhibition of carbonic anahydrases with glycosyltriazole benzene sulfonamides. J. Med. Chem. 2008, 51, 1945–1953. - PubMed
-
- Wilkinson B. L.; Bornaghi L. F.; Houston T. A.; Innocenti A.; Vullo D.; Supuran C. T.; Poulsen S. A. Carbonic anhydrase inhibitors: Inhibition of isozymes I, II and IX with triazole-linked O-glycosides of benzene sulfonamides. J. Med. Chem. 2007, 50, 1651–1657. - PubMed
-
- Morris J. C.; Chiche J.; Grellier C.; Lopez M.; Bornaghi L. F.; Maresca A.; Supuran C. T.; Pouyssegur J.; Poulsen S. A. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. J. Med. Chem. 2011, 54, 6905–6918. - PubMed
-
- Supuran C. T. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discovery 2008, 7, 168–181. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
